Livzon Pharmaceutical Group Inc. (SHE: 000513)

Livzon Pharmaceutical Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Jan 1, 2021	Jan 1, 2020
Cash & Equivalents	11,498	11,326	10,411	9,146	9,954	8,855
Trading Asset Securities	67.94	81.79	108.09	182.77	25.98	17.19
Cash & Short-Term Investments	11,566	11,408	10,519	9,329	9,980	8,873
Cash Growth	5.84%	8.44%	12.76%	-6.52%	12.48%	3.12%
Accounts Receivable	3,731	3,575	4,039	3,294	2,892	2,425
Other Receivables	64.11	51.91	31.32	64.37	92.85	120.37
Receivables	3,795	3,627	4,071	3,358	2,985	2,546
Inventory	1,974	2,061	2,045	1,663	1,488	1,169
Other Current Assets	171.72	171.11	352	322.42	174.88	286
Total Current Assets	17,507	17,266	16,987	14,673	14,627	12,873
Property, Plant & Equipment	4,542	4,566	4,592	4,239	3,707	3,394
Long-Term Investments	1,680	1,670	1,738	1,695	988.09	651.24
Goodwill	124.91	124.91	103.04	103.04	103.04	103.04
Other Intangible Assets	420.26	426.28	557.44	260.28	236.43	229.56
Long-Term Deferred Tax Assets	323.9	301.92	283.89	252.69	238.23	182.66
Long-Term Deferred Charges	491.05	468.62	416.74	704.41	373.49	259.84
Other Long-Term Assets	487.47	221.17	189.66	444.62	317.09	283.33
Total Assets	25,576	25,045	24,868	22,372	20,591	17,976
Accounts Payable	1,715	1,658	1,862	1,817	1,625	1,270
Accrued Expenses	3,343	3,295	3,249	2,656	2,467	2,173
Short-Term Debt	1,850	1,860	1,622	2,043	1,551	1,361
Current Portion of Long-Term Debt	1,453	647.47	-	-	-	-
Current Portion of Leases	13.94	12.2	10.44	9.28	8.54	-
Current Income Taxes Payable	129.69	181.58	92.57	97.45	179.51	138.66
Current Unearned Revenue	86.73	138	226.19	167.8	104.45	151.77
Other Current Liabilities	1,106	294.49	334.42	134.34	147.17	199.46
Total Current Liabilities	9,697	8,087	7,397	6,925	6,083	5,294
Long-Term Debt	714.28	1,613	1,974	636.78	360.32	-
Long-Term Leases	7.77	9.03	11.61	5.27	10.1	-
Long-Term Unearned Revenue	256.12	269.37	273.21	258.88	276.14	246.68
Long-Term Deferred Tax Liabilities	203.11	209.81	191.96	156.89	143.28	90.88
Other Long-Term Liabilities	90	90	84	78	78	70
Total Liabilities	10,969	10,278	9,932	8,061	6,951	5,701
Common Stock	926.33	923.94	935.55	937.87	944.84	934.76
Additional Paid-In Capital	1,063	1,030	1,422	1,629	1,457	1,091
Retained Earnings	11,575	11,653	11,182	10,461	9,682	9,042
Treasury Stock	-73.45	-	-55.94	-71.21	-250.06	-
Comprensive Income & Other	428.72	435.62	391.64	46.55	273.78	98.69
Total Common Equity	13,920	14,042	13,876	13,004	12,107	11,167
Minority Interest	687.51	724.21	1,060	1,307	1,533	1,108
Shareholders' Equity	14,607	14,767	14,936	14,311	13,640	12,275
Total Liabilities & Equity	25,576	25,045	24,868	22,372	20,591	17,976
Total Debt	4,039	4,141	3,619	2,694	1,930	1,361
Net Cash (Debt)	7,528	7,266	6,901	6,635	8,050	7,512
Net Cash Growth	12.86%	5.29%	4.01%	-17.58%	7.16%	5.76%
Net Cash Per Share	8.13	7.81	7.37	7.09	8.58	8.04
Filing Date Shares Outstanding	924.17	923.94	932.23	929.97	932.47	934.76
Total Common Shares Outstanding	924.17	923.94	932.23	929.97	944.84	934.76
Working Capital	7,810	9,179	9,591	7,748	8,544	7,580
Book Value Per Share	15.06	15.20	14.88	13.98	12.81	11.95
Tangible Book Value	13,375	13,491	13,216	12,640	11,768	10,834
Tangible Book Value Per Share	14.47	14.60	14.18	13.59	12.45	11.59
Buildings	-	-	-	3,123	2,970	2,864
Machinery	8,407	8,296	7,577	3,764	3,216	2,856
Construction In Progress	373.68	289.31	602.44	554.58	385.7	233.49

Source: S&P Capital IQ. Standard template. Financial Sources.